554 results on '"Berman C"'
Search Results
2. Rethinking Tolerance to Tourism: Behavioral Responses by Wild Crested Macaques (Macaca nigra) to Tourists
3. EP11.03-20 Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre
4. Generating conditional atomic entanglement by measuring photon number in a single output channel
5. Individual Differences in Response to Sibling Birth among Free-Ranging Yearling Rhesus Monkeys (Macaca mulatta) on Cayo Santiago
6. Parkinsonismo en varón joven
7. Improved Logic Optimization Using Global-Flow Analysis
8. Functional Comparison of Logic Designs for VLSI Circuits
9. Sentinel Lymphadenectomy: A Safe Answer to Less Axillary Surgery?
10. Maternal Condition and Offspring Sex Ratio in a Group of Free-Ranging Rhesus Monkeys: An Eleven-Year Study
11. Responses of Free-Ranging Rhesus Monkeys to a Natural Form of Social Separation. I. Parallels with Mother-Infant Separation in Captivity
12. Reproductive Consequences of Maternal Care Patterns during Estrus among Free-Ranging Rhesus Monkeys
13. 818TiP REFRaME-O1/ENGOT-OV79/GOG-3086: A phase II/III open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice of chemotherapy in women with relapsed platinum-resistant epithelial ovarian cancer expressing folate receptor alpha (FolRα)
14. 741MO Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion
15. 138 Phase 1 dose-escalation study of STRO-002, an anti-folate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced platinum-resistant/refractory epithelial ovarian cancer (OC)
16. Fascia lata sling cystourethropexy for the management of female urinary incontinence
17. INDIVIDUAL DIFFERENCES IN RESPONSE TO SIBLING BIRTH AMONG FREE-RANGING YEARLING RHESUS MONKEYS (MACACA MULATTA) ON CAYO SANTIAGO
18. Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase III study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial
19. Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF trial
20. Combustion of Aerosolized Metal Particles in Microgravity
21. Radiographic patterns of PLH/LIP in HIV positive children
22. The Use of Intraoperative Radiolymphoscintigraphy for Sentinel Node Biopsy in Patients with Malignant Melanoma
23. Dagga (cannabis) usage among medical students in Johannesburg
24. Direct computation of turbulence and noise
25. Time-dependent jet flow and noise computations
26. HALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA)
27. Early results from an open-label phase 1b/II study of eribulin mesylate (EM) + pegvorhyaluronidase alfa (PEGHP20) combination for the treatment of patients with HER2-negative, high-hyaluronan (HA) metastatic breast cancer (MBC)
28. The effect of smoking on achieving osseointegration of surface-modified implants: a clinical report.
29. A Proposal for a Network of Psychiatric Treatment Services: A Unitization Model
30. 832TiP - Infigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase III study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial
31. P-225 - Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF trial
32. 789TiP - HALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untreated hyaluronan (HA)-high stage IV pancreatic ductal adenocarcinoma (PDA)
33. 311P - Early results from an open-label phase 1b/II study of eribulin mesylate (EM) + pegvorhyaluronidase alfa (PEGHP20) combination for the treatment of patients with HER2-negative, high-hyaluronan (HA) metastatic breast cancer (MBC)
34. Early agonistic experience and rank acquisition among free-ranging infant rhesus monkeys
35. Are katamenia a first potentiality or first actuality of a human?
36. P0907 : Pharmacokinetics, pharmacodynamics, and toxicity profile of RG-101, a novel GalNAc-conjugated hepatocyte-targetng inhibitor of microrna-122, in rodents and cynomolgus monkeys
37. Some Analytical Consideration in Jet Noise Prediction
38. Grooming interchange for resource tolerance: biological markets principles within a group of free-ranging rhesus macaques.
39. Community Nutrition Course Gains Service Learning Designation by Offering Cooking Matters for Child Care Professionals Curriculum
40. MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: Apreliminary report.
41. MENSTRUAL FUNCTION AND UNDERNUTRITION IN BALLET DANCERS: 244
42. MENSTRUAL FUNCTION AND UNDERNUTRITION IN BALLET DANCERS: 244
43. Creole Subjects in the Colonial Americas: Empires, Texts, Identities. Ed. by Ralph Bauer and Jose Antonio Mazzotti. (Chapel Hill: University of North Carolina Press, 2009. xiv, 503 pp. Cloth, $75.00, ISBN 978-0-8078-3213-4. Paper, $27.50, ISBN 978-0-8078-5968-1.)
44. The Known World in World Literature: Bakhtin, Glissant, and Edward P. Jones
45. Phase Ib/II pharmacokinetic/pharmacodynamic (PK/PD) study of combination voreloxin and cytarabine in relapsed or refractory AML patients
46. A phase II study of voreloxin as single agent therapy for elderly patients (pts) with newly diagnosed acute myeloid leukemia (AML)
47. Simultaneous computation of jet turbulence and noise
48. Effects of motion on jet exhaust noise from aircraft
49. Phase 1 trial of SNS-314, a novel selective inhibitor of aurora kinases A, B, and C, in advanced solid tumor patients
50. PHP4 THE IMPACT OF COPAYMENTS OR BRAND NAMED DRUG ON MEDICATION PERSISTENCE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.